Literature DB >> 23836485

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation.

David Kremer1, Tanja Schichel, Moritz Förster, Nevena Tzekova, Corinne Bernard, Paul van der Valk, Jack van Horssen, Hans-Peter Hartung, Hervé Perron, Patrick Küry.   

Abstract

OBJECTIVE: Differentiation of oligodendroglial precursor cells is crucial for central nervous system remyelination and is influenced by both extrinsic and intrinsic factors. Recent studies showed that human endogenous retrovirus type W (HERV-W) contributes significantly to brain damage. In particular, its envelope protein ENV can mediate injury to specific cell types of the brain and immune system. Here, we investigated whether ENV protein affects oligodendroglial differentiation.
METHODS: Immunostaining and gene expression analyses were performed to establish the expression and regulation of the known ENV receptor, Toll-like receptor 4 (TLR4), on oligodendroglial precursor cells in human brain tissue and in culture. Cultured primary oligodendroglial precursor cells were stimulated with ENV protein to determine the effects of this ligand/receptor interaction.
RESULTS: We demonstrated that the ENV protein is present in close proximity to TLR4-expressing oligodendroglial precursor cells adjacent to multiple sclerosis lesions. Human and rat oligodendroglial precursor cells expressed TLR4, and the ENV-mediated activation of TLR4 led to the induction of proinflammatory cytokines and inducible nitric oxide synthase as well as the formation of nitrotyrosine groups and a subsequent reduction in myelin protein expression.
INTERPRETATION: Our findings suggest that ENV-mediated induction of nitrosative stress via activation of TLR4 results in an overall reduction of the oligodendroglial differentiation capacity, thereby contributing to remyelination failure. Therefore, pharmacological or antibody-mediated inhibition of ENV may prevent the blockade of myelin repair in the diseased or injured central nervous system.
© 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836485     DOI: 10.1002/ana.23970

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  62 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

Review 2.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

3.  pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.

Authors:  David Kremer; Joel Gruchot; Vivien Weyers; Lisa Oldemeier; Peter Göttle; Luke Healy; Jeong Ho Jang; Yu Kang T Xu; Christina Volsko; Ranjan Dutta; Bruce D Trapp; Hervé Perron; Hans-Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

4.  Human retrovirus pHEV-W envelope protein and the pathogenesis of multiple sclerosis.

Authors:  Robert P Lisak
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-09       Impact factor: 11.205

5.  On the origin of a pathogenic HERV-W envelope protein present in multiple sclerosis lesions.

Authors:  Klemens Ruprecht; Jens Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-27       Impact factor: 11.205

6.  Reply to Ruprecht and Mayer: Unearthing genomic fossils in the pathogenesis of multiple sclerosis.

Authors:  David Kremer; Hervé Perron; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-27       Impact factor: 11.205

7.  Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study.

Authors:  François Curtin; Virginie Vidal; Corinne Bernard; Arno Kromminga; Alois B Lang; Hervé Porchet
Journal:  MAbs       Date:  2016-03-30       Impact factor: 5.857

8.  Human endogenous retrovirus W family envelope protein (HERV-W env) facilitates the production of TNF-α and IL-10 by inhibiting MyD88s in glial cells.

Authors:  Xiuling Wang; Xiulin Wu; Jin Huang; Haiyan Li; Qiujin Yan; Fan Zhu
Journal:  Arch Virol       Date:  2021-01-12       Impact factor: 2.574

9.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

Review 10.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.